| Literature DB >> 33936301 |
Sanam B Rajper1, Mujtaba Moazzam2, Arsheen Zeeshan1, Qalab Abbas1.
Abstract
BACKGROUND: Critically ill individuals have an increased risk of acute symptomatic seizures secondary to systemic illnesses; unrecognized or untreated seizures can quickly convert into status epilepticus, which is associated with high morbidity and mortality.Entities:
Keywords: Acute symptomatic seizure; antiepileptic drug (AEDs); critical ill children
Year: 2021 PMID: 33936301 PMCID: PMC8078641 DOI: 10.4103/jpn.JPN_140_19
Source DB: PubMed Journal: J Pediatr Neurosci ISSN: 1817-1745
Characteristic of acute symptomatic seizure with demographics
| Variables | Value |
|---|---|
| Mean age (SD) in months | 75 (SD ± 54.4) |
| Age distribution | |
| Less than 1 years | 38 (36%) |
| 1.1–5 years | 34 (32%) |
| 5.1–10 years | 12 (11%) |
| 10.1–18 years | 22 (21%) |
| Gender | |
| Male | 63 (59.5%) |
| Female | 43 (40.5%) |
| Male-to-female ratio | 1.5:1 |
| Seizure occurred | |
| Present with seizure in emergency room | 48 (45%) |
| Developed seizure in ICU | 58 (55%) |
| Type of seizure | |
| Generalized seizure | 70 (66%) |
| Focal seizure | 32 (30.2%) |
| Subtle seizure | 4 (3.8%) |
| Seizure duration | |
| Less than 5 min | 69 (65%) |
| 5–10 min | 27 (25%) |
| More than 10 min | 10 (10%) |
| Use of long antiepileptic drug (AEDs) for seizure control after short-acting drug | |
| One AED used | 87 (82.2%) |
| Two AEDs used | 10 (9.4%) |
| More than 2 | 7 (6.6%) |
| No AEDS used | 2 (1.8%) |
| Antiepileptic drug (AEDs) | |
| Midazolam (short acting to abort seizure) | 106 (100%) |
| Levetiracetam (as first long- acting drug) | 94 (89%) |
| Phenobarbitone | 14 (13%) (in three patients as first AEDs, in four patients as second AEDs, and in seven patients of status epilepticus) |
| Phenytoin | 15 (14%) (in four patients as first AEDs, in four patients as second AEDs, and in seven patients of status epilepticus) |
| Sodium valproate | 12 (11%) (in three patients as first AEDs, in four patients as second AEDs, and in seven patients of status epilepticus) |
| Midazolam infusion | 7 (6.6%) |
| Propofol infusion | 7 (6.6%) |
| Etiology | |
| Sepsis | 21 (20%) |
| Meningoencephalitis | 21 (20%) |
| Complicated pneumonia | 18 (17%) |
| Road traffic accident | 7 (6.5%) |
| Congenital heart disease | 3 (3%) |
| Known case of epilepsy with status epilepticus | 7 (6.5%) |
| Others (post bone marrow transplant for thalassemia major, dengue hemorrhage fever, poisoning, and inborn error of metabolism) | 29 (27%) |
| Electrolyte imbalance | 94 (88.6%) |
| Acute kidney injury | 81 (76%) |
| Inotropic support | 98 (91.6%) |
| Ventilator support | 93 (86.9%) |
| EEG | |
| Abnormal | 92 (86%) |
| Normal | 14 (14%) |
| EEG finding | |
| Focal epileptic discharges | 7 (6.6%) |
| Generalized epileptic discharges | 5 (4.8%) |
| Status epilepticus | 7 (6.6%) |
| Background slowing | 73 (69%) |
| Normal | 14 (14%) |
| Outcome | |
| Expired | 37 (35%) |
| No neurological deficit | 51 (48%) |
| Neurological deficit | 18 (17%) |